These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4619768)

  • 21. Double-blind evaluation of deanol in tardive dyskinesia.
    Penovich P; Morgan JP; Kerzner B; Karch F; Goldblatt D
    JAMA; 1978 May; 239(19):1997-8. PubMed ID: 347112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined suxilep-depakine (dipropylacetate) therapy in children with suxilep-resistant pyknolepsy].
    Todt H; Wünsche W; Korth G
    Kinderarztl Prax; 1977 Apr; 45(4):175-6. PubMed ID: 406476
    [No Abstract]   [Full Text] [Related]  

  • 23. Valproate sodium: a controlled clinical trial including monitoring of drug levels.
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jorgensen A; Sommerbeck KW; Lohren V
    Epilepsia; 1977 Jun; 18(2):141-8. PubMed ID: 326542
    [No Abstract]   [Full Text] [Related]  

  • 24. Huntington's disease: treatment with dipropylacetic acid and gamma-aminobutyric acid.
    Shoulson I; Kartzinel R; Chase TN
    Neurology; 1976 Jan; 26(1):61-3. PubMed ID: 128707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sodium di-n-propylacetate: evaluation of its so-called psychotropic effect. A controlled study].
    Sommerbeck KW; Theilgaard A; Rasmussen KE; Løhren V; Gram L; Wulff K
    Ugeskr Laeger; 1977 May; 139(18):1069-73. PubMed ID: 324059
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Dimethylaminoethanol for tardive dyskinesia.
    Escobar JI; Kemp KF
    N Engl J Med; 1975 Feb; 292(6):317-8. PubMed ID: 1110712
    [No Abstract]   [Full Text] [Related]  

  • 27. 2-dimethylaminoethanol (Deanol) in Huntington's chorea.
    Caraceni TA; Girotti F; Celano I; Parati E; Balboni L
    J Neurol Neurosurg Psychiatry; 1978 Dec; 41(12):1114-8. PubMed ID: 153384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of choreic syndromes with sodium dipropylacetate].
    Piccinin G; Morocutti C; Urcioli R; Bernardi G
    Riv Neurol; 1977; 47(2):107-16. PubMed ID: 141095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Deanol in spontaneous and induced dyskinesias.
    Laterre EC; Fortemps E
    Lancet; 1975 Jun; 1(7919):1301. PubMed ID: 48933
    [No Abstract]   [Full Text] [Related]  

  • 30. Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.
    Saft C; Lauter T; Kraus PH; Przuntek H; Andrich JE
    BMC Neurol; 2006 Feb; 6():11. PubMed ID: 16507108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of ergenyl (dipropylacetate) in hypsarrhythmia].
    Rohmann E; Arndt R
    Kinderarztl Prax; 1976 Mar; 44(3):109-13. PubMed ID: 775170
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Deanol for tardive dyskinesia.
    N Engl J Med; 1975 Apr; 292(17):926-7. PubMed ID: 1117921
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind trial of 2-dimethylaminoethanol in Alzheimer's disease.
    Fisman M; Mersky H; Helmes E
    Am J Psychiatry; 1981 Jul; 138(7):970-2. PubMed ID: 7020434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electromyographic assessment of dimethylaminoethanol (deanol) in treatment of tardive dyskinesia.
    Lonowski DJ; Sterling FE; King HA
    Psychol Rep; 1979 Oct; 45(2):415-9. PubMed ID: 538170
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Deanol for tardive dyskinesia.
    Casey DE
    N Engl J Med; 1975 Aug; 293(7):359. PubMed ID: 1152930
    [No Abstract]   [Full Text] [Related]  

  • 37. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of Deanol on amnesic disorders. A preliminary trial (author's transl)].
    Caffarra P; Cattelani R; Mazzucchi A; Moretti G; Parma M
    Ateneo Parmense Acta Biomed; 1980; 51(4):383-9. PubMed ID: 7470191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current concepts in drug therapy.
    Ceylon Med J; 1976 Sep; 21(3):208-9. PubMed ID: 800352
    [No Abstract]   [Full Text] [Related]  

  • 40. Deanol in tardive dyskinesia.
    Davis KL; Berger PA; Hollister LE
    Am J Psychiatry; 1977 Jul; 134(7):807. PubMed ID: 869061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.